EQS-Ad-hoc: RHÖN-KLINIKUM Aktiengesellschaft / Key word(s): Personnel Bad Neustadt a. d. Saale, 18 October 2022 RHÖN-KLINIKUM AG: Changes on the Board of Management The Chief Executive Officer of RHÖN-KLINIKUM AG, Dr. Christian Höftberger, asked the Chairman of the Supervisory Board of the company last week to terminate his contract ahead of schedule. Consequently, the Supervisory Board resolved today, in a meeting convened at short notice, to comply with this request. With this consensual step, both Dr. Christian Höftberger and the Supervisory Board would like to create room for new dynamics in the stalled negotiations between RHÖN-KLINIKUM AG and the State of Hesse on securing the future of the University Hospital Gießen and Marburg (UKGM) in the interests of the employees and all patients of UKGM. As the new Chief Executive Officer of RHÖN-KLINIKUM AG, the Supervisory Board has appointed Prof. Dr. Tobias Kaltenbach, who will take office on 1 November 2022. In addition, the Supervisory Board has decided to reduce the size of the company's Board of Management to three members. Prof. Dr. Bernd Griewing will move in his function as CMO (Chief Medical Officer) to the position of a General Representative. As of 1 November 2022, the Board of Management will thus consist of Prof. Dr. Tobias Kaltenbach (CEO), Dr. Stefan Stranz (CFO) and Dr. Gunther K. Weiß (COO).
RHÖN-KLINIKUM AG T. +49 9771 65-12250 | julian.schmitt@rhoen-klinikum-ag.com
RHÖN-KLINIKUM AG | Schlossplatz 1 | D-97616 Bad Neustadt a. d. Saale
18-Oct-2022 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
Language: | English |
Company: | RHÖN-KLINIKUM Aktiengesellschaft |
Salzburger Leite 1 | |
97616 Bad Neustadt a.d.Saale | |
Germany | |
Phone: | +49 (0)9771 - 65-0 |
Fax: | +49 (0)9771 - 97 467 |
E-mail: | rka@rhoen-klinikum-ag.com |
Internet: | www.rhoen-klinikum-ag.com |
ISIN: | DE0007042301 |
WKN: | 704230 |
Listed: | Regulated Market in Frankfurt (Prime Standard), Munich; Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Stuttgart, Tradegate Exchange |
EQS News ID: | 1466081 |
End of Announcement | EQS News Service |
|
1466081 18-Oct-2022 CET/CEST
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.